Table 1.
Patient number | Sex | Age | Birth country | Number of lesions; lesion location | Diagnosis | Duration of disease | Treatment course |
---|---|---|---|---|---|---|---|
1 | M | 28 | Somalia | 1, right thumb | CL (L. panamensis) | 5 weeks | First: LAmB (Days 1–7, 10, 14) Second: LAmB (Days 1–14, 17, 21) |
2 | M | 22 | Somalia | 1, right pinna | CL (L. panamensis) | 5 weeks | LAmB (Days 1–7, 10, 14) |
3 | M | 21 | Somalia | 1, left lateral foot | CL (L. panamensis) | 4 weeks | First: LAmB (Days 1–7, 10, 14) Second: LAmB (Days 1–14, 17, 21) |
4 | M | 26 | Ethiopia | 1, right posterior calf | CL (L. panamensis) | 8 weeks | LAmB (Days 1–7, 10, 14) |
5† | M | 24 | Somalia | 3, medial thigh-bilaterally | CL (L. panamensis) | No report† | LAmB (Days 1–7, 10, 14) |
Description of individual patient demographics (M = male); lesion location, number, and duration; diagnosis (CL = cutaneous leishmaniasis); treatment course(s) (LAmB = liposomal amphotericin B).
Patient 5 refused to disclose any information about his journey.